These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

229 related articles for article (PubMed ID: 31994639)

  • 1. "Black box" pharmacogenetic decision-support tools in psychiatry.
    Bousman CA; Eyre HA
    Braz J Psychiatry; 2020 Apr; 42(2):113-115. PubMed ID: 31994639
    [No Abstract]   [Full Text] [Related]  

  • 2. The coming-of-age of pharmacogenetic testing in clinical psychiatry.
    Yoshida K; Müller DJ; Kennedy JL
    Psychiatry Clin Neurosci; 2019 May; 73(5):203. PubMed ID: 31045316
    [No Abstract]   [Full Text] [Related]  

  • 3. Beyond the bins: interpreting and discussing pharmacogenomic reports with psychiatric patients.
    Dunlop BW
    Braz J Psychiatry; 2020 Apr; 42(2):111-112. PubMed ID: 31994637
    [No Abstract]   [Full Text] [Related]  

  • 4. Pharmacogenetics in psychiatric care, a call for uptake of available applications.
    Lunenburg CATC; Gasse C
    Psychiatry Res; 2020 Oct; 292():113336. PubMed ID: 32739644
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Towards the integration of pharmacogenetics in psychiatry: a minimum, evidence-based genetic testing panel.
    Bousman C; Maruf AA; Müller DJ
    Curr Opin Psychiatry; 2019 Jan; 32(1):7-15. PubMed ID: 30299306
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Clinical utility of pharmacogenetic testing in children and adolescents with severe mental disorders.
    Blasco-Fontecilla H
    J Neural Transm (Vienna); 2019 Jan; 126(1):101-107. PubMed ID: 29626260
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Navigating the Labyrinth of Pharmacogenetic Testing: A Guide to Test Selection.
    Bousman CA; Zierhut H; Müller DJ
    Clin Pharmacol Ther; 2019 Aug; 106(2):309-312. PubMed ID: 31004441
    [No Abstract]   [Full Text] [Related]  

  • 8. [Pharmacogenetics in daily practice].
    van Gelder T; van Schaik RHN
    Ned Tijdschr Geneeskd; 2020 Jun; 164():. PubMed ID: 32608920
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Pharmacogenetic associations and evidence-based pharmacogenomics guidelines: supporting label and off-label use of drug-gene interaction data.
    Kisor DF; Monte AA; Müller DJ
    Pharmacogenomics; 2020 May; 21(7):427-430. PubMed ID: 32319356
    [No Abstract]   [Full Text] [Related]  

  • 10. Pharmacogenetic testing in psychiatry: not (quite) ready for primetime.
    Howland RH
    J Psychosoc Nurs Ment Health Serv; 2014 Nov; 52(11):13-6. PubMed ID: 25375387
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Re: Pharmacogenetic Testing Options Relevant to Psychiatry in Canada.
    Dawes M; Katzov-Eckert H; Paterson A; Dawes D
    Can J Psychiatry; 2020 Aug; 65(8):584-585. PubMed ID: 32400175
    [No Abstract]   [Full Text] [Related]  

  • 12. Pharmacogenetic clinical decision support for psychiatric hospitalization: Design of the CYP-GUIDES randomized controlled trial.
    Ruaño G; Holford T; Seip RL; Goethe JW; Mehendru R
    Contemp Clin Trials; 2019 Aug; 83():27-36. PubMed ID: 31247284
    [No Abstract]   [Full Text] [Related]  

  • 13. Pharmacogenomic Testing in Psychiatry: Ready for Primetime?
    Rakesh G; Sumner CR; Alexander JL; Gross LS; Pine J; Slaby A; Garakani A; Baron D
    J Nerv Ment Dis; 2020 Feb; 208(2):127-130. PubMed ID: 31895226
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Pharmacogenetic guidelines and decision support tools for depression treatment: application to late-life.
    Chang DD; Eyreeuro HA; Abbott R; Coudreaut M; Baune BT; Shaman JA; Lavretsky H; Lenze EJ; Merrill DA; Singh AB; Mulsant BH; Reynolds CF; Müller DJ; Bousman C
    Pharmacogenomics; 2018 Nov; 19(16):1269-1284. PubMed ID: 30422065
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Review and Consensus on Pharmacogenomic Testing in Psychiatry.
    Bousman CA; Bengesser SA; Aitchison KJ; Amare AT; Aschauer H; Baune BT; Asl BB; Bishop JR; Burmeister M; Chaumette B; Chen LS; Cordner ZA; Deckert J; Degenhardt F; DeLisi LE; Folkersen L; Kennedy JL; Klein TE; McClay JL; McMahon FJ; Musil R; Saccone NL; Sangkuhl K; Stowe RM; Tan EC; Tiwari AK; Zai CC; Zai G; Zhang J; Gaedigk A; Müller DJ
    Pharmacopsychiatry; 2021 Jan; 54(1):5-17. PubMed ID: 33147643
    [TBL] [Abstract][Full Text] [Related]  

  • 16. [Personalized medicine in psychiatry -- an old concept from a new aspect].
    Molnar JM
    Neuropsychopharmacol Hung; 2012 Mar; 14(1):2-3. PubMed ID: 22427465
    [No Abstract]   [Full Text] [Related]  

  • 17. Psychotropic pharmacogenetics.
    Singh AB
    Aust N Z J Psychiatry; 2016 Jun; 50(6):596-8. PubMed ID: 27208005
    [No Abstract]   [Full Text] [Related]  

  • 18. Tools for optimizing pharmacotherapy in psychiatry (therapeutic drug monitoring, molecular brain imaging and pharmacogenetic tests): focus on antidepressants.
    de Leon J
    Pharmacogenomics; 2021 Aug; 22(13):805-808. PubMed ID: 34344160
    [No Abstract]   [Full Text] [Related]  

  • 19. Recommendations for pharmacogenetic testing in clinical practice guidelines in the US.
    Hertz DL; Bousman CA; McLeod HL; Monte AA; Voora D; Orlando LA; Crutchley RD; Brown B; Teeple W; Rogers S; Patel JN
    Am J Health Syst Pharm; 2024 Aug; 81(16):672-683. PubMed ID: 38652504
    [TBL] [Abstract][Full Text] [Related]  

  • 20. [How to individualize drug therapy based on pharmacogenetic information? A systematic review of published guidelines].
    Hafner S; Haubensak S; Paul T; Zolk O
    Dtsch Med Wochenschr; 2016 Oct; 141(21):e183-e202. PubMed ID: 27750332
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 12.